Transcenta Investors

22 investors on Angel Roster list Transcenta in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Series B and the largest groups are based in China, the United States and Taiwan.

Investors are matched on the company name in their portfolio, so companies that share the name Transcenta can appear together.

Investors listed
22
With verified email
55%
Most common stage
Series B
Top location
China

Updated October 13, 2026 · How we compile this data

Top 22 Transcenta investors

The most complete profiles first. Showing 22 of 22.

  • Carol SuhVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • David CruikshankVerified

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceBiotechnologyHardware

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Helen ChenVerified

    Venture Capital, Investment Bank, Investor · China

    SeedAdvertisingHealth CareCustomer ServicePayments

    Portfolio: ioranges Automation, Jbhope, Ifensi.com, Yee Coffee and 59 more

    Verified email available

  • Sean KendallVerified

    Venture Capital, Private Equity Firm, Investor · United Kingdom

    Series BHealth CareEnterprise SoftwareEnergyChemical

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Bing XiaoVerified

    Venture Capital · China

    Health CareE-commerceEnterprise SoftwareTrading Platform

    Portfolio: ACTION, UCAS, Yujia, OptoMedic and 87 more

    Verified email available

  • Fei ChenVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • John LiuVerified

    Investment Bank · China

    AdvertisingHealth CareCustomer ServicePayments

    Portfolio: ioranges Automation, Jbhope, Ifensi.com, Yee Coffee and 59 more

    Verified email available

  • Judith LiVerified

    Venture Capital · Hong Kong

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Kun HuangVerified

    Venture Capital · China

    Health CareE-commerceEnterprise SoftwareTrading Platform

    Portfolio: ACTION, UCAS, Yujia, OptoMedic and 87 more

    Verified email available

  • Mark McDonnellVerified

    Venture Capital · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Richard ChewVerified

    Venture Capital · Taiwan

    Health CareE-commerceEnterprise SoftwareTrading Platform

    Portfolio: ACTION, UCAS, Yujia, OptoMedic and 87 more

    Verified email available

  • Tom BrennanVerified

    Venture Capital, Private Equity Firm · United States

    Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Verified email available

  • Yi ShiVerified

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Verified email available

  • Corey Ritter

    Venture Capital, Investor · United States

    Series BHealth CareLife ScienceRoboticsManufacturing

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Nilay Thakar

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more

    Contact details available

  • Steve Gillis

    Venture Capital, Private Equity Firm, Investor · United States

    Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more

    Contact details available

  • Dehua Hu

    Venture Capital · China

    Health CareE-commerceEnterprise SoftwareTrading Platform

    Portfolio: ACTION, UCAS, Yujia, OptoMedic and 87 more

    Contact details available

  • James Chew

    Venture Capital · Taiwan

    Health CareE-commerceEnterprise SoftwareTrading Platform

    Portfolio: ACTION, UCAS, Yujia, OptoMedic and 87 more

    Contact details available

  • Jieyu Zou

    Venture Capital · China

    Health CareGeneticsWomen FoundedInvestment Management

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Ling Su

    Venture Capital · China

    Health CareGeneticsWomen FoundedLife Science

    Portfolio: KSQ Therapeutics, xInnovent Biologics, Abbisko Therapeutics, Microtech Medical and 59 more

    Contact details available

  • Renjie Xiong

    Venture Capital · China

    Health CareE-commerceEnterprise SoftwareTrading Platform

    Portfolio: ACTION, UCAS, Yujia, OptoMedic and 87 more

    Contact details available

  • Robert Nelsen

    Venture Capital, Investor · United States

    Health CareLife ScienceBiotechnologyHealth Diagnostics

    Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more

    Contact details available

Frequently asked questions

How many Transcenta investors are on Angel Roster?

Angel Roster lists 22 Transcenta investors. 12 of them (55%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (21), Private Equity Firms (4) and Investment Banks (2). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Transcenta investors invest in?

Among those that list a stage, the most common are Series B (6) and Seed (1).

Where are Transcenta investors based?

Most are based in China (10), the United States (8) and Taiwan (2).

Which companies have Transcenta investors backed?

The most-backed portfolio companies among them are Qihan Biotech (14), Sonoma BioTherapeutics (14), KSQ Therapeutics (14), Geneception (14) and Metacrine (14).

How do I contact Transcenta investors?

Create a free Angel Roster account to search and filter all 22, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.